FI257674A - - Google Patents

Info

Publication number
FI257674A
FI257674A FI2576/74A FI257674A FI257674A FI 257674 A FI257674 A FI 257674A FI 2576/74 A FI2576/74 A FI 2576/74A FI 257674 A FI257674 A FI 257674A FI 257674 A FI257674 A FI 257674A
Authority
FI
Finland
Application number
FI2576/74A
Other languages
Finnish (fi)
Other versions
FI62281B (fi
FI62281C (fi
Inventor
G L Florvall
S-O Oegren
S B Ross
Original Assignee
Astra Laekemedel Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE7312001A external-priority patent/SE382047B/xx
Application filed by Astra Laekemedel Ab filed Critical Astra Laekemedel Ab
Publication of FI257674A publication Critical patent/FI257674A/fi
Publication of FI62281B publication Critical patent/FI62281B/fi
Application granted granted Critical
Publication of FI62281C publication Critical patent/FI62281C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/06Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14Radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
FI2576/74A 1973-09-04 1974-09-03 Foerfarande foer framstaellning av antidepressivt verksamma 4-minoamfetaminderivat FI62281C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7312001A SE382047B (sv) 1973-09-04 1973-09-04 Forfarande for framstellning av 4-aminoamfetaminderivat
SE7312002 1973-09-04

Publications (3)

Publication Number Publication Date
FI257674A true FI257674A (de) 1975-03-05
FI62281B FI62281B (fi) 1982-08-31
FI62281C FI62281C (fi) 1982-12-10

Family

ID=20318423

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2576/74A FI62281C (fi) 1973-09-04 1974-09-03 Foerfarande foer framstaellning av antidepressivt verksamma 4-minoamfetaminderivat

Country Status (16)

Country Link
US (1) US3996381A (de)
JP (1) JPS5835177B2 (de)
AT (1) AT336566B (de)
BE (1) BE819515A (de)
CA (1) CA1051436A (de)
CH (2) CH603547A5 (de)
DE (1) DE2440734C2 (de)
DK (1) DK139716B (de)
FI (1) FI62281C (de)
FR (1) FR2242079B1 (de)
GB (1) GB1461667A (de)
HK (1) HK75778A (de)
IE (1) IE40514B1 (de)
LU (1) LU70852A1 (de)
NL (1) NL7411753A (de)
NO (2) NO139408C (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2427388C (en) * 2000-11-01 2011-12-20 Sention, Inc. Pharmaceutical compositions and uses for improving memory and learning impairments
US20070117869A1 (en) * 2000-11-01 2007-05-24 Cognition Pharmaceuticals Llc Methods for treating coginitive impairment and improving cognition
US20050059743A1 (en) * 2000-11-01 2005-03-17 Sention, Inc. Methods for treating mild cognitive impairment and alzheimer's disease
US7619005B2 (en) * 2000-11-01 2009-11-17 Cognition Pharmaceuticals Llc Methods for treating cognitive impairment in humans with Multiple Sclerosis
US20030232890A1 (en) * 2000-11-01 2003-12-18 Sention, Inc. Methods for treating an impairment in memory consolidation
US20030119884A1 (en) * 2000-11-01 2003-06-26 Epstein Mel H. Methods and compositions for regulating memory consolidation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3117160A (en) * 1961-07-27 1964-01-07 Pfizer & Co C Aralkylamines
US3496195A (en) * 1966-05-11 1970-02-17 Chinoin Gyogyszer Es Vegyeszet D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts

Also Published As

Publication number Publication date
DK464774A (de) 1975-05-05
AT336566B (de) 1977-05-10
JPS5835177B2 (ja) 1983-08-01
FI62281B (fi) 1982-08-31
NO142624B (no) 1980-06-09
IE40514B1 (en) 1979-06-20
US3996381A (en) 1976-12-07
CH599106A5 (de) 1978-05-12
NL7411753A (nl) 1975-03-06
CH603547A5 (de) 1978-08-31
FR2242079A1 (de) 1975-03-28
JPS5050329A (de) 1975-05-06
GB1461667A (en) 1977-01-19
CA1051436A (en) 1979-03-27
AU7283374A (en) 1976-03-04
DE2440734C2 (de) 1985-01-24
FI62281C (fi) 1982-12-10
BE819515A (fr) 1975-03-04
IE40514L (en) 1975-03-04
DK139716C (de) 1979-09-17
DK139716B (da) 1979-04-02
NO791507L (no) 1975-03-05
LU70852A1 (de) 1975-06-11
NO139408C (no) 1979-03-07
DE2440734A1 (de) 1975-03-13
NO743177L (de) 1975-04-01
NO142624C (no) 1980-09-17
NO139408B (no) 1978-11-27
FR2242079B1 (de) 1978-07-21
HK75778A (en) 1979-01-05
ATA702574A (de) 1976-09-15

Similar Documents

Publication Publication Date Title
AU476761B2 (de)
AU465372B2 (de)
AU474593B2 (de)
AU474511B2 (de)
AU474838B2 (de)
AU465453B2 (de)
AU465434B2 (de)
AU471343B2 (de)
AU450229B2 (de)
AU476714B2 (de)
FR2242079B1 (de)
AU466283B2 (de)
AU476696B2 (de)
NO743170L (de)
AU477823B2 (de)
AU471461B2 (de)
AU477824B2 (de)
AU461342B2 (de)
AU447540B2 (de)
AU476873B1 (de)
CH1281373A4 (de)
BG19911A1 (de)
AU479496A (de)
AU479458A (de)
AU479453A (de)